TH28830B - Elements which have an anti-fengjai effect. - Google Patents
Elements which have an anti-fengjai effect.Info
- Publication number
- TH28830B TH28830B TH9601001492A TH9601001492A TH28830B TH 28830 B TH28830 B TH 28830B TH 9601001492 A TH9601001492 A TH 9601001492A TH 9601001492 A TH9601001492 A TH 9601001492A TH 28830 B TH28830 B TH 28830B
- Authority
- TH
- Thailand
- Prior art keywords
- azol
- azole
- fengjai
- elements
- effect
- Prior art date
Links
- 230000000694 effects Effects 0.000 title abstract 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 claims abstract 6
- 238000000034 method Methods 0.000 claims abstract 5
- PLIKAWJENQZMHA-UHFFFAOYSA-N 4-aminophenol Chemical compound NC1=CC=C(O)C=C1 PLIKAWJENQZMHA-UHFFFAOYSA-N 0.000 claims abstract 3
- 239000000126 substance Substances 0.000 claims 2
- VHVPQPYKVGDNFY-DFMJLFEVSA-N 2-[(2r)-butan-2-yl]-4-[4-[4-[4-[[(2r,4s)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one Chemical compound O=C1N([C@H](C)CC)N=CN1C1=CC=C(N2CCN(CC2)C=2C=CC(OC[C@@H]3O[C@](CN4N=CN=C4)(OC3)C=3C(=CC(Cl)=CC=3)Cl)=CC=2)C=C1 VHVPQPYKVGDNFY-DFMJLFEVSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- 229960004884 fluconazole Drugs 0.000 claims 1
- RFHAOTPXVQNOHP-UHFFFAOYSA-N fluconazole Chemical group C1=NC=NN1CC(C=1C(=CC(F)=CC=1)F)(O)CN1C=NC=N1 RFHAOTPXVQNOHP-UHFFFAOYSA-N 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 229960004130 itraconazole Drugs 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 abstract 1
- 229940122680 Demethylase inhibitor Drugs 0.000 abstract 1
- 206010017533 Fungal infection Diseases 0.000 abstract 1
- 208000031888 Mycoses Diseases 0.000 abstract 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 108010017796 epoxidase Proteins 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229940031439 squalene Drugs 0.000 abstract 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 abstract 1
Abstract
การใช้ของส่วนผสมของสควาลีน อีพอกชิเดส อินฮิบิเตอร์เทอร์บิเนไฟน์ และอะโชล 14 อัลฟ่า -เมทธิลดีเมทธิลเลส อินฮิบิเตอร์ ในการติดเชื้อเนื่องมาจากเชื้อราที่เกิดจากเชื้อ ฟังไจชนิดที่มีความทนทานต่ออะโซล และองค์ประกอบที่ให้ผลในทาง เภสัช กระบวนการและกรรมวิธี The use of a mixture of squalene, epoxidase inhibitor, turbinefine and azole 14 alpha-methyl demethylase inhibitor in Infected due to a fungal infection Azol-resistant hearing jai And constituents that produce effects in pharmaceuticals, processes and processes
Claims (1)
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH28830B true TH28830B (en) | 1998-06-10 |
| TH28830A TH28830A (en) | 1998-06-10 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE292462T1 (en) | TREATMENT OF ASTHMA USING MEK INHIBITORS | |
| ATE204164T1 (en) | PLASTER FOR THE TREATMENT OF NAIL MYCOSIS | |
| GEP20022786B (en) | Purine Inhibitors of Cyclin Dependent Kinase 2 and 1kB-a | |
| SE0104248D0 (en) | Method of treatment | |
| DE69909818D1 (en) | PYRAZOLOPYIMIDINONE DERIVATIVES FOR TREATING IMPOTENCE | |
| BR0308854A (en) | Substituted benzazoles and their uses as raf kinase inhibitors | |
| FI973492A0 (en) | NO synthase inhibitors | |
| ATE299890T1 (en) | INHIBITORS OF GAMMA SECRETASE | |
| ATE210449T1 (en) | METHOD AND COMPOSITION FOR REDUCING MYOCARDIAL REPERFUSION DAMAGE | |
| DK0799209T3 (en) | sulfonamides | |
| WO2003002114A3 (en) | Use of potent, selective and non toxic c-kit inhibitors for treating mastocytosis | |
| DE60133029D1 (en) | MEANS FOR THE PREVENTION OR TREATMENT OF PSORIASI | |
| DE60234577D1 (en) | PHARMACEUTICAL MIXTURE FOR THE TREATMENT OF CANCER CONTAINING DIOXOLANE NUCLEOSIDE ANALOGUE | |
| ATE396174T1 (en) | HYDROXYALKYLAMINE DERIVATIVES AS BETA-SECRETASE INHIBITORS AND THE USE THEREOF FOR THE TREATMENT OF ALZHEIMER'S DISEASE OR SIMILAR DISEASES | |
| WO2003024386A3 (en) | Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis | |
| IS2789B (en) | Medicinal preparations containing monoamine oxidase B inhibitors | |
| DE60327557D1 (en) | USE OF SPONGOSIN (2-METHOXYADENOSINE) FOR THE TREATMENT OF PAIN, IN PARTICULAR HYPERALGESIS | |
| DE602004011255D1 (en) | PHOSPHINIC ACID DERIVATIVES, INHIBITORS OF BETA-SEKRETASE FOR THE TREATMENT OF ALZHEIMER DISEASE | |
| WO2003092606A3 (en) | Cholinesterase inhibitors to prevent injuries caused by chemicals | |
| MXPA03005380A (en) | Antifungal nail composition and method of use. | |
| WO2003101382A3 (en) | Compounds useful in the treatment of anthrax and inhibiting lethal factor | |
| BR0312470A (en) | Compound, use thereof, pharmaceutical composition, method of treating and / or preventing cancer, and process for preparing the compound | |
| ATE321045T1 (en) | METHODS AND COMPOSITIONS FOR TREATING PAIN | |
| ATE240377T1 (en) | CLAY CONTAINING MIXTURE OF DRY SOLIDS WHICH CAN BE USED TO PRODUCE A MOISTURE RESISTANT GEL AND METHOD OF TREATING A SURFACE | |
| BRPI0409405A (en) | substituted 7-aza-quinazoline compounds |